background evaluate safety efficacy proton radiation therapy prt intracranial astrocytomas authors analyzed NUMBER pediatric patients treated loma linda university medical center llumc patients method september NUMBER august NUMBER NUMBER patients NUMBER female NUMBER male underwent fractionated proton radiation therapy progressive recurrent astrocytoma age time treatment ranged NUMBER NUMBER years mean NUMBER years tumors located centrally diencephalic NUMBER patients cerebral cerebellar hemispheres seven patients brainstem patients patients NUMBER treated progressive unresectable residual disease following subtotal resection tissue diagnosis available patients NUMBER patients optic pathway tumors treated histologic confirmation target doses NUMBER NUMBER cge cobalt gray equivalent mean NUMBER cge prescribed NUMBER cge fraction treatments week results mean period NUMBER years years patients experienced local failure located irradiated field patients died anatomic site data translated rates local control survival NUMBER patients NUMBER patients central tumors NUMBER patients NUMBER patients hemispheric tumors NUMBER patients NUMBER patients tumors located brainstem proton radiation therapy generally tolerated children local control maintained performance status child associated neurofibromatosis type NUMBER developed moyamoya disease patients optic pathway tumors useful vision maintained improved visual status conclusions report pediatric astrocytomas confirms proton radiation therapy safe efficacious conformal treatment modality results encouraging central tumors large optic pathway tumors dose conformity particular importance difficult achieve longer time needed fully evaluate benefits normal tissue sparing low grade low grade follow NUMBER NUMBER low grade NUMBER d follow NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER